Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Assets Average (2020 - 2025)

Goldenwell Biotech (GWLL) has disclosed Assets Average for 6 consecutive years, with $235852.5 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average rose 24.19% year-over-year to $235852.5, compared with a TTM value of $235852.5 through Sep 2025, up 24.19%, and an annual FY2024 reading of $226143.0, down 5.08% over the prior year.
  • Assets Average was $235852.5 for Q3 2025 at Goldenwell Biotech, up from $221605.0 in the prior quarter.
  • Across five years, Assets Average topped out at $497511.5 in Q3 2021 and bottomed at $189636.0 in Q3 2023.
  • Average Assets Average over 5 years is $278748.5, with a median of $233911.0 recorded in 2023.
  • The sharpest move saw Assets Average soared 89.7% in 2021, then tumbled 45.68% in 2022.
  • Year by year, Assets Average stood at $473413.0 in 2021, then plummeted by 45.66% to $257238.5 in 2022, then fell by 19.33% to $207513.5 in 2023, then dropped by 2.75% to $201812.0 in 2024, then increased by 16.87% to $235852.5 in 2025.
  • Business Quant data shows Assets Average for GWLL at $235852.5 in Q3 2025, $221605.0 in Q2 2025, and $208053.5 in Q1 2025.